Association of 1,25 dihydroxyvitamin D with left ventricular hypertrophy and left ventricular diastolic dysfunction in patients with chronic kidney disease
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302849 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jemin Hyeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea. Hauptthemen laut MEDLINE: Hypertrophy, Left Ventricular, Renal Insufficiency, Chronic, Vitamin D, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Busan National University of Education.
Abstract (Originalsprache)
Left ventricular hypertrophy (LVH) and left ventricular diastolic dysfunction (LVDD) are highly prevalent predictors of cardiovascular disease in individuals with chronic kidney disease (CKD). Vitamin D, particularly 25-hydroxyvitamin D [25(OH)D], deficiency has been reported to be associated with cardiac structure and function in CKD patients. In the current study, we investigated the association between 1,25-dihydroxyvitamin D [1,25(OH) 2 D], the active form of 25(OH)D, and LVH/LVDD in CKD patients. We enrolled 513 non-dialysis CKD patients. The presence of LVH and LVDD was determined using transthoracic echocardiography. In multivariable analysis, serum 1,25(OH) 2 D levels, but not serum 25(OH)D, were independently associated with LVH [odds ratio (OR): 0.90, 95% confidential interval (CI): 0.88–0.93, P < 0.001]. Additionally, age, systolic blood pressure, and intact parathyroid hormone levels were independently associated with LVH. Similarly, multivariable analysis demonstrated that serum 1,25(OH) 2 D levels, but not 25(OH)D levels, were independently associated with LVDD (OR: 0.88, 95% CI: 0.86–0.91, P < 0.001) with systolic blood pressure showing independent association with LVDD. The optimal cut-off values for serum 1,25(OH) 2 D levels for identifying LVH and LVDD were determined as ≤ 12.7 pg/dl and ≤ 18.1 pg/dl, respectively. Our findings suggest that serum 1,25(OH) 2 D levels have independent association with LVH and LVDD in CKD patients, underscoring their potential as biomarkers for these conditions in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
- Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
ORCID-Profile: Jemin Hyeon, Suji Kim, Seo Rin Kim, Il Young Kim
Förderung
- Busan National University of Education
Zitieren
APA
Hyeon, J., Kim, S., Ye, B. M., Kim, S. R., Lee, D. W., Lee, S. B., & Kim, I. Y. (2024). Association of 1,25 dihydroxyvitamin D with left ventricular hypertrophy and left ventricular diastolic dysfunction in patients with chronic kidney disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0302849
Vancouver
Hyeon J, Kim S, Ye BM, Kim SR, Lee DW, Lee SB, et al. Association of 1,25 dihydroxyvitamin D with left ventricular hypertrophy and left ventricular diastolic dysfunction in patients with chronic kidney disease. PLOS ONE. 2024. doi:10.1371/journal.pone.0302849
BibTeX
@article{Hyeon2024,
author = {Hyeon, Jemin and Kim, Suji and Ye, Byung Min and Kim, Seo Rin and Lee, Dong Won and Lee, Soo Bong and Kim, Il Young},
title = {Association of 1,25 dihydroxyvitamin D with left ventricular hypertrophy and left ventricular diastolic dysfunction in patients with chronic kidney disease},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302849}
}
EUVIMED